Cleared Special

K230414 - ClariVy™ Cervical IBF System (FDA 510(k) Clearance)

May 2023
Decision
85d
Days
Class 2
Risk

K230414 is an FDA 510(k) clearance for the ClariVy™ Cervical IBF System. This device is classified as a Intervertebral Fusion Device With Bone Graft, Cervical (Class II - Special Controls, product code ODP).

Submitted by Vy Spine, LLC (Tallahassee, US). The FDA issued a Cleared decision on May 12, 2023, 85 days after receiving the submission on February 16, 2023.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3080. Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft..

Submission Details

510(k) Number K230414 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 16, 2023
Decision Date May 12, 2023
Days to Decision 85 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code ODP — Intervertebral Fusion Device With Bone Graft, Cervical
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.

Similar Devices — ODP Intervertebral Fusion Device With Bone Graft, Cervical

All 24
Dakota LP System
K250769 · Precision Spine, Inc. · Nov 2025
IdentiTi II Cervical Interbody System
K251080 · Alphatec Spine, Inc. · Jul 2025
FIX-C 3D Ti ACIF System
K243915 · Jeil Medical Corporation · Feb 2025
ClariVy™ Cervical IBF System
K231836 · Vy Spine, LLC · Oct 2023
HAtetracell™-C Titanium Cervical IBF System
K231899 · Innovasis, Inc. · Oct 2023
NuVasive CoRoent Small Interbody System
K231735 · Nu Vasive, Incorporated · Jul 2023